Table 1 Demographic and clinical characteristics of the participants in the current study.
Characteristics | AVH (n = 64) | NAVH (n = 40) | HC (n = 90) | F/t/X2 | p value |
|---|---|---|---|---|---|
Gender (male/female) | 32/32 | 20/20 | 44/46 | 0.02 | 0.98 |
Age, years (SD) | 23.36 (8.30) | 23.70 (7.04) | 22.70 (6.15) | 0.33 | 0.72 |
Education, years (SD) | 11.73 (3.52) | 12.45 (2.81) | 12.76 (2.50) | 2.23 | 0.11 |
Illness Duration, month (SD) | 15.03 (23.48) | 13.33 (23.88) | - | 0.35 | 0.73 |
GAF | 29.60 (12.03) | 31.64 (11.27) | - | -0.85 | 0.40 |
PANSS | |||||
PANSS total (SD) | 91.72 (19.53) | 84.05 (16.28) | - | 2.07 | 0.04 |
PANSS positive (SD) | 25.53 (5.48) | 20.70 (5.81) | - | 4.27 | <0.01 |
PANSS negative (SD) | 19.94 (9.46) | 17.56 (7.06) | - | 1.47 | 0.15 |
PANSS general (SD) | 46.25 (9.60) | 45.80 (9.61) | - | 0.23 | 0.82 |
PANSS Hallucination P3 (SD) | 4.86 (1.08) | 1.28 (0.45) | - | 23.43 | <0.01 |
PANSS positive minus P3 (SD) | 20.67 (5.13) | 19.43 (5.73) | - | 1.15 | 0.25 |
PANSS total minus P3 (SD) | 86.86 (19.27) | 82.78 (16.16) | - | 1.12 | 0.27 |
